乳腺癌化疗期间当代和时间症状驱动因素:一个前性的重复措施队列研究
Minyu Liang1, Jia Li1, Jiagen Xiang2
1School of Nursing, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong Province, China.
概括
这项研究确定了乳腺癌患者化疗期间的关键症状. 早期干预应侧重于身体症状,中期治疗应侧重于心理症状,晚期治疗应侧重于神经毒性,以更好地控制症状.
科学领域:
- 在瘤学瘤学.
- 精神瘤学 精神瘤学
- 生物统计学 生物统计学
背景情况:
- 乳腺癌 (I-III阶段) 的化疗往往导致复杂的症状体验.
- 识别驱动其他症状的特定症状对于有效的患者管理至关重要.
研究的目的:
- 在统计学上描述当代和时间症状网络.
- 确定强大的,特定阶段的干预目标,用于化疗期间的症状管理.
主要方法:
- 对153名接受化疗的乳腺癌患者进行前性队列研究.
- 在四个周期中利用MD安德森症状库存数据.
- 采用探索性因子分析,高斯图形模型和交叉滞后面板网络.
主要成果:
- 症状集群在整个化疗周期内从3个演变为2个.
- 关键的当代司机包括食欲丧失,悲伤和麻木.
- 时间驾驶者预测未来的症状是呼吸短促,悲伤和昏昏欲睡.
结论:
- 发现了一个动态的,双重机制的症状框架 (截面和时间).
- 建议采取特定阶段的干预措施:体质 (早期),心理 (中期) 和神经毒性 (晚期).
- 这种方法在管理化疗相关症状方面提供了精确的方法.
相关概念视频
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
602
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
602
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
588
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
588
Observational Studies
10.7K
Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
10.7K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
814
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
814

